×
Back to Agenda
Session 5: Safety Reporting – Guidance on Use of new RSI and Outstanding Issues
Session Chair(s)
Willemijn van der Spuij, MSc
Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland
Session 5: Safety Reporting – Guidance on Use of new RSI and Outstanding Issues
Speaker(s)
Regulators Perspective
Massimiliano Sarra, PhD, MPH
Permanent official and CTFG Secretary, Italian Medicine Agency (AIFA), Italy
Industry Perspective
Willemijn van der Spuij, MSc
Executive Director Europe | International - Patient Safety, Bristol Myers Squibb, Switzerland
Have an account?